 | Up a level |
Reichen, Juerg (2010). ACP Journal Club. Telaprevir combination therapy induced a sustained virologic response in nonresponsive chronic HCV infection. Annals of internal medicine, 153(4), JC2-7. Philadelphia, Pa.: American College of Physicians 10.1059/0003-4819-153-4-201008170-02007
Trebicka, Jonel; Hennenberg, Martin; Odenthal, Margarete; Shir, Khanwali; Klein, Sabine; Granzow, Michaela; Vogt, Annabelle; Dienes, Hans-Peter; Lammert, Frank; Reichen, Jürg; Heller, Jörg; Sauerbruch, Tilman (2010). Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. Journal of hepatology, 53(4), pp. 702-12. Amsterdam: Elsevier 10.1016/j.jhep.2010.04.025
Bruegger, Lukas; Studer, Peter; Schmid, Stefan W; Pestel, Gunther; Reichen, Juerg; Seiler, Christian; Candinas, Daniel; Inderbitzin, Daniel (2008). Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. Journal of gastrointestinal surgery, 12(1), pp. 67-72. New York, N.Y.: Springer-Verlag 10.1007/s11605-007-0352-3
Veldt, Bart J; Chen, Wendong; Heathcote, E Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, W Peter; de Knegt, Robert J; Zeuzem, Stefan; Manns, Michael P; Hansen, Bettina E; Schalm, Solko W; Janssen, Harry L A (2008). Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology, 47(6), pp. 1856-62. Hoboken, N.J.: Wiley Interscience 10.1002/hep.22251
Torgerson, Paul R; Schweiger, Alexander; Deplazes, Peter; Pohar, Maja; Reichen, Jürg; Ammann, Rudolf W; Tarr, Philip E; Halkik, Nerman; Müllhaupt, Beat (2008). Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. Journal of hepatology, 49(1), pp. 72-7. Amsterdam: Elsevier 10.1016/j.jhep.2008.03.023
Reichen, Juerg (2008). Review: ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary biliary cirrhosis. ACP journal club, 148(1), p. 17. Philadelphia, Pa.: American College of Physicians
Knapp, Andrea Caroline; Todesco, Liliane; Beier, Konstantin; Terracciano, Luigi; Sägesser, Hans; Reichen, Jürg; Krähenbühl, Stephan (2008). Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores. Journal of pharmacology and experimental therapeutics, 324(2), pp. 568-75. Bethesda, Md.: American Society for Pharmacology and Experimental Therapeutics 10.1124/jpet.107.131185
Schweiger, Alexander; Ammann, Rudolf W; Candinas, Daniel; Clavien, Pierre-Alain; Eckert, Johannes; Gottstein, Bruno; Halkic, Nerman; Muellhaupt, Beat; Prinz, Bettina Mareike; Reichen, Juerg; Tarr, Philip E; Torgerson, Paul R; Deplazes, Peter (2007). Human alveolar echinococcosis after fox population increase, Switzerland. Emerging infectious diseases, 13(6), pp. 878-882. Atlanta, Ga.: U.S. National Center for Infectious Diseases
Schoepfer, AM; Engel, A; Fattinger, K; Marbet, UA; Criblez, D; Reichen, J; Zimmermann, A; Oneta, CM (2007). "Herbal" does not mean "innocuous": 10 Cases of Severe Hepatotoxicity Associated with Dietary Supplements from Herbalife (R) Products. Journal of hepatology, 47(4), pp. 521-526. Amsterdam: Elsevier 10.1016/j.jhep.2007.06.014
Russmann, Stefan; Dowlatshahi, Emmilia A; Printzen, Gert; Habicht, Susanne; Reichen, Jürg; Zimmermann, Heinz (2007). Prevalence and associated factors of viral hepatitis and transferrin elevations in 5036 patients admitted to the emergency room of a Swiss university hospital: cross-sectional study. BMC gastroenterology, 7, p. 5. London: BioMed Central 10.1186/1471-230X-7-5
Reichen, Jürg; Lebrec, Didier (2007). The future treatment of portal hypertension. Best practice & research - clinical gastroenterology, 21(1), pp. 191-202. London: Baillière Tindall 10.1016/i.bpg.2006.07.006
Veldt, Bart J; Heathcote, E Jenny; Wedemeyer, Heiner; Reichen, Juerg; Hofmann, W Peter; Zeuzem, Stefan; Manns, Michael P; Hansen, Bettina E; Schalm, Solko W; Janssen, Harry L A (2007). Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Annals of internal medicine, 147(10), pp. 677-84. Philadelphia, Pa.: American College of Physicians
Neef, M; Ledermann, M; Saegesser, H; Schneider, V; Reichen, J (2007). Corrigendum to "Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis"... Journal of hepatology, 47(2), p. 310. Amsterdam: Elsevier 10.1016/j.jhep.2007.06.003
Studer, P; Bruegger, L; Schmid, S; Pestel, G; Gloor, B; Reichen, J; Seiler, CA; Inderbitzin, D; Candinas, D (2007). Indocyanine green plasma disappearance rate during the anhepatic phase of orthotopic liver transplantation. British journal of surgery, pp. 761-84. Bristol, UK: John Wright & Sons
Barth, Florian; Gerber, Peter J; Reichen, Jürg; Dufour, Jean-François; Nicod, Laurent P (2006). Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency. European journal of gastroenterology & hepatology, 18(10), pp. 1117-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.meg.0000231749.60889.f7
Reichen, Juerg (2006). Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for non-alcoholic fatty liver disease. Evidence-based medicine, 11(1), p. 26. Philadelphia, Pa.: American College of Physicians
De Gottardi, Andrea; Biecker, Erwin; Koshy, Abraham; Bohler, Dieter; Shaw, Sidney; Sägesser, Hans; Reichen, Jürg (2006). Sensitivity to endothelin-1 is decreased in isolated livers of endothelial constitutive nitric oxide synthase knockout mice. Comparative hepatology, 5, p. 9. London: BioMed Central 10.1186/1476-5926-5-9
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Reichen, Juerg (2006). Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Journal of hepatology, 45(6), pp. 786-96. Amsterdam: Elsevier 10.1016/j.jhep.2006.07.030
Reichen, Jürg (2006). Entecavir was more effective than lamivudine in HbeAg-positive chronic hepatitis B. ACP journal club, 145(1), p. 18. Philadelphia, Pa.: American College of Physicians
Shaw, Sidney G; Boden, Jane P; Biecker, Erwin; Reichen, Juerg; Rothen, Barbara (2006). Endothelin antagonism prevents diabetic retinopathy in NOD mice: a potential role of the angiogenic factor adrenomedullin. Experimental biology and medicine, 231(6), pp. 1101-5. Maywood, N.J.: Society for Experimental Biology & Medicine
Müller, NJ; Furrer, H; Kaiser, L; Hirschel, B; Cavassini, M; Fellay, J; Chave, JP; Wüthrich, RP; Weber, M; Müllhaupt, B; Candinas, D; Reichen, J; Giostra, E; Mentha, G; Halkic, N; Hirsch, HH; Weber, R; Swiss, HIV Cohort Study (2006). HIV and solid organ transplantation: the Swiss experience. Swiss medical weekly, 136(11-12), pp. 194-6. Muttenz: EMH Schweizerischer Ärzteverlag
Bihl, Florian; Emmenegger, Urban; Reichen, Jürg; Neftel, Klaus A; Zimmermann, Arthur; Cerny, Andreas (2006). Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis. Journal of hepatology, 44(6), pp. 1208-12. Amsterdam: Elsevier 10.1016/j.khep.2006.03.003
Reichen, Jürg (2006). Quantitative liver tests in living liver donors and their recipients. Liver transplantation, 12(4), pp. 514-5. Hoboken, N.J.: Wiley 10.1002/lt.20694
Gschossmann, J M; Essig, M; Reichen, J; Scheurer, U; Gerken, G (2006). The hepato-pulmonary syndrome--where do we stand in the year 2006? Zeitschrift für Gastroenterologie, 44(3), pp. 249-56. Stuttgart: Thieme 10.1055/s-2005-858995
Reichen, Juerg (2006). Age, impaired fasting glucose, and cirrhosis predicted mortality at mean 7.6 years for nonalcoholic fatty liver disease. ACP journal club, 144(1), p. 22. Philadelphia, Pa.: American College of Physicians
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Widmer, Nicolas; Decosterd, Laurent Arthur; Rochat, Bertrand; Reichen, Juerg (2006). Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of hepatology, 44(1), pp. 167-75. Amsterdam: Elsevier 10.1016/j.jhep.2005.06.015
Inderbitzin, Daniel; Muggli, Beat; Ringger, Annette; Beldi, Guido; Gass, Markus; Gloor, Beat; Uehlinger, Dominik; Regli, Bruno; Reichen, Jürg; Candinas, Daniel (2005). Molecular absorbent recirculating system for the treatment of acute liver failure in surgical patients. Journal of gastrointestinal surgery, 9(8), pp. 1155-1162. Springer-Verlag 10.1016/j.gassur.2005.07.026
Beyeler, C.; Reichen, J.; Thomann, S. R.; Lauterburg, B H; Gerber, N. J. (1997). Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study. British journal of rheumatology, 36(3), pp. 338-344. Oxford University Press 10.1093/rheumatology/36.3.338
